招募完成
试验总结
一项III期、开放标签、申办者盲态、随机研究，旨在评估Dato-DXd联合或不联合奥希替尼对比含铂双药化疗，用于既往奥希替尼治疗后疾病进展的EGFR突变局部晚期或转移性非小细胞肺癌受试者。
Who can participate
Clinical trials can have restrictive criteria of who can and can’t participate, talk to your healthcare provider if you are interested in this clinical trial.